Multi‐institutional experience of stereotactic body radiotherapy for large (≥5 centimeters) non–small cell lung tumors
Vivek Verma(Christ University), Charles B. Simone(New York Proton Center), Roy H. Decker(Yale University), Sameera Kumar(Fox Chase Cancer Center), Matthew M. Harkenrider(Loyola University Chicago), John M. Stahl(Yale University), Hanmanth J. Neboori(University of Miami), Fiori Alite(Loyola University Chicago), Brian Bingham(Vanderbilt University), C. Hadzitheodorou(Rutgers, The State University of New Jersey), Christopher L. Hallemeier(Mayo Clinic in Arizona), Kyle Wang(University of North Carolina at Chapel Hill), Salma K. Jabbour(Rutgers, The State University of New Jersey), Valerie Shostrom(University of Nebraska Medical Center), Joshua M. Walker(Oregon Health & Science University), Steve Braunstein(University of California, San Francisco), John Holland(Oregon Health & Science University), Albert Attia(Vanderbilt University), Weining Zhen(Susan Thompson Buffett Foundation), Adrian S. Iskhanian(University of Miami), Ronald C. McGarry(University of Kentucky), Percy Lee(University of California, Los Angeles)
Cited by 99
Related Papers
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Estimating Survival in Patients With Lung Cancer and Brain Metastases
|JAMA Oncology|2016|655
NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018
|Journal of the National Comprehensive Cancer Network|2018|632
Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases
|JAMA Oncology|2022|557